The groundbreaking treatment of this peptide represents a major development in the management of type 2 diabetes. Unlike existing drugs, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide691077.fitnell.com/83135895/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment